177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Clinical trial NCT07189871 · RECRUITING

Trial details

NCT number: NCT07189871
Sponsor: Radiopharm Theranostics, Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Castration-Resistant Prostate Cancer (CRPC)Colorectal Cancer NSCLC (Non-small Cell Lung Cancer)Ovarian Cancer Cervical Cancer Endometrial Cancer TNBC, Triple Negative Breast Cancer Small Cell Lung Cancer (SCLC )Head &Amp; Neck Squamous Cell Carcinoma (HNSCC)Esophageal Squamous Cell Carcinoma (ESCC)

Start date: 2026-02-23
Primary completion: 2027-12-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.